Bide Pharmatech Co. Ltd. A (688073) — Cash Flow Quality Index
Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow Quality Index of 0.19x as of December 2025. Operating cash flow of CN¥28.32 Million is below net income of CN¥151.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688073 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bide Pharmatech Co. Ltd. A Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Bide Pharmatech Co. Ltd. A.
Annual Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A (2020–2025)
Year-by-year earnings quality comparison for Bide Pharmatech Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥28.32 Million | CN¥151.74 Million | ▼ -86.2% |
| 2024 | 1.35x | CN¥158.31 Million | CN¥117.43 Million | ▲ +357.4% |
| 2023 | -0.52x | CN¥-57.39 Million | CN¥109.57 Million | ▼ -355.9% |
| 2022 | 0.20x | CN¥29.87 Million | CN¥145.97 Million | ▲ +130.8% |
| 2021 | -0.66x | CN¥-64.88 Million | CN¥97.57 Million | ▼ -1176.4% |
| 2020 | 0.06x | CN¥3.65 Million | CN¥59.00 Million | — |